Replies to post #225752 on Biotech Values

[DewDiligence]

LCTX—(+21%)—inks Roche collaboration to develop cell therapy for dry AMD and other ocular diseases:

https://finance.yahoo.com/news/lineage-establishes-exclusive-worldwide-collaboration-110000449.html

$50M up-front cash.